GRCE financials
Grace Therapeutics (GRCE) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
GRCE income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2026 | – | – | -$11.08M | -$7.79M | -0.47 |
| 2025 | – | – | -$16.68M | -$9.57M | -0.79 |
| 2024 | – | – | -$12.85M | -$12.85M | -1.35 |
| 2023 | – | – | -$52.16M | -$42.43M | -5.71 |
| 2022 | $0.00 | $0.00 | -$15.59M | -$9.82M | -1.62 |
| 2021 | $196.00K | $120.00K | -$16.42M | -$19.68M | -7.98 |